New Test From Quest Diagnostics Helps Physicians Choose HIV Antiretroviral Therapy In Patients With History Of Drug Resistance
New Test From Quest Diagnostics Helps Physicians Choose HIV Antiretroviral Therapy In Patients With History Of Drug Resistance - Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced the availability of a new laboratory developed test designed to help physicians determine whether a patient with a history of HIV drug resistance will respond to the latest class of HIV antiretroviral therapies. [Medical News HIV/AIDS]
- rosa's blog
- Login or register to post comments
- 127 reads

